RECENT ADVANCES IN CHEMOTHERAPY OF LUNG CANCER USING NOVEL DRUG DELIVERY SYSTEM
Lokendra Singh Thakur, Kuneeta Ahirwar, Mahima Jain, Amit Choudhary, Pushpendra Kumar Khangar*
ABSTRACT
Cancer is one of the most common diseases that results in a large number of fatalities worldwide. Lung cancer is the most chronic type of cancer in the world, according to the major types of cancer. Lung cancer is typically treated with a combination of medical procedures such as chemotherapy, surgical removal, and radiation therapy. Nanocarrier technologies are currently being employed widely to exploit and overcome the blockages caused by lung cancer. Because the goal of nano-carrier-loaded therapeutic drug delivery systems is to inhibit the proliferation of tumour cells, they have showed promise in treating lung cancer. Various techniques of nano drug delivery, such as liposomes, dendrimers, quantum dots, carbon nanotubes, and metallic nanoparticles, are reviewed in this review. Nanocarrier drug delivery systems appear to be a promising strategy, and as a result, fresh and more advanced paths in cancer therapies are predicted to open up
[Full Text Article]